Citation of paper, A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
Hideto Kameda3661,3612.6
Young H Lee24357,6532.3
Alexandre Rocha Sepriano2612,89413.1
Louise Falzon2849,34637.3
Maarten de Wit21089,17217.6
Joao Goncalves21383,9333.4
10
Keiichiro Nishida11223,3372.4
Isao Matsushita1241531
Osman N Yogurtcu1173512
Vibeke Strand125813,9976
Yuhong Yuan11486,1008.5
Bergithe E Oftedal1368223.6
Bernard Combe128227,06410
Bogdan Batko1232031.7
George Han1341,8668.1
10
Filipe C Araújo120
Yuko Kaneko1911,2503
David Armstrong11867,3883.9
Masaaki Mori1991,7062
Masataka Kohno1261961.1
Salvatore Leone Bba19462.1
Alessandro Armuzzi11235,8737.5
João E Fonseca11613,6283.4
Michael L Tee11640313
Kelly A Reynolds Ba1241252.4
Roman A Ivanov1342541.1
Davide G Ribaldone11701,4742.5
Elena P Ilivanova1151.7
Masayo Kojima1750.4
Yasumori Sobue18150.8
Anette Susanne Bøe Wolff1562,8065.4
Flavio Caprioli11224,9047
Takeo Nakayama1251621.3
Ekaterina V Chernyaeva110541.3
Takahiko Sugihara1172042
Fabrizio Cantini1522,00210.5
B G Feagan138145,55413.3
Ekaterina A Dokukina12155.8
Masayoshi Harigai1982,3364.2
Yohei Seto19591
Alexander M Lila1792301.8
Olga B Nesmeyanova1151.7
Ambrogio Orlando1902,2544.5
Akio Morinobu1534481.7
Fabrizio Bossa11013,5984.8
Kishimoto Mitsumasa1254366.3
Yutaka Kawahito11333,9142.1
Carlos Abud-Mendoza1441,6355.7